Abcam
Danaher to Acquire Abcam for $5.7B
Cambridge, UK-based Abcam provides antibodies, reagents, biomarkers, and assays for drug discovery, life sciences research, and diagnostics.
Abcam to License Phage Library from Twist Bioscience for Antibody Discovery, Diagnostics
The deal "lays the foundations for a long-term collaboration with Abcam to drive new commercial opportunities," Twist CEO Emily Leproust said.
Abcam, MEDx Expand Cancer Diagnostics Development Alliance
The companies began working together in 2018, when MEDx was known as Qiagen Translational Medicine, on companion and in vitro diagnostics.
Avacta, Abcam Ink Distribution Agreement for SARS-CoV-2 Laboratory Test Reagents
Avacta said that the deal will enable scientists to perform a laboratory test to detect the SARS-CoV-2 spike protein and some of its dominant variants.
Abingdon Health, Abcam Ink Comarketing Agreement for Reagent, Lateral Flow Testing Products
The firms said that Abcam will be the preferred supplier of gold nanoparticles and custom conjugation reagents and services for Abingdon's lateral flow assays.
Nov 5, 2019
Opko Health Q3 Revenues Down 8 Percent
May 7, 2018